Discover
ONCY
Oncolytics Biotech Inc.
0.90
2 x 0.65
2 x 1.18
bid
ask
-
0.05
5.18%
2 @ 04:00 PM
0.93 +0.03 (3.41%)
| Ytd | 3.53% | |
| 1y | 14.01% |
0.90
day range
0.96
0.71
52 week range
1.51
| Open | 0.93 | Prev Close | 0.95 | Low | 0.90 | High | 0.96 | Mkt Cap | 107.50M |
| Vol | 649.41K | Avg Vol | 1.31M | EPS | -0.32 | P/E | N/A | Forward P/E | -3.02 |
| Beta | 1.51 | Short Ratio | 3.51 | Inst. Own | 1.76% | Dividend | N/A | Div Yield | N/A |
| Ex Div Date | N/A | Earning | 08-06 | 50-d Avg | 0.91 | 200-d Avg | 1.02 | 1yr Est | 4.85 |
ONCY News
benzinga.com
Oncolytics Biotech Receives New U.S. Patent For Its Proprietary Manufacturing Process For Pelareorep
Oncolytics Biotech® Inc. (Nasdaq: ONCY) ("Oncolytics" or the "Company"), a clinical-
benzinga.com
Oncolytics Biotech Promotes John McAdory To COO
Oncolytics Biotech® Inc. (NASDAQ:ONCY) ("Oncolytics" or the "Company"), a clinical-s
benzinga.com
Oncolytics Biotech Announces Initial Data From Preclinical Study Supporting Further Evaluation Of Pe
Oncolytics Biotech® Inc. (NASDAQ:ONCY) ("Oncolytics" or the "Company"), a clinical-s